Market Leads & Opportunities
Pipeline Framework: Specialised – Human Cell Line Recombinant Factor VIII
A pipeline has been launched for Specialised – Human Cell Line Recombinant Factor VIII.The contract start Date is 01 February 2019. Approach to market date is 01 September 2018.NHS National Framework Agreement for Human Cell Line Recombinant Factor VIIIThis is a potential opportunity from the government, and the pipeline gives advance notice of an opportunity that might be offered by the public sector in the future – allowing potential suppliers to plan accordingly. When a public sector organisation publishes a pipeline notice, it does not necessarily mean that an opportunity will be offered in the future.For more information contact: Commercial Medicines Unit, 2nd Floor, Rutland House, Runcorn, WA7 2ES, England. Email alison.greenwood3@nhs.net.
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million. - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre.
- In association with::
